Home / business / AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology

AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology

-
Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in cash and shares to bolster its positions in immunology and rare diseases.

from Top Business News- News18.com
Read The Rest:timesnownews...
AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology AstraZeneca To Buy Alexion For $39 Billion To Expand In Immunology Reviewed by Team Exprssnews on December 12, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.